Timing of Cardio-Kidney Protection with SGLT2 Inhibitors: Insights from Four Large-scale Placebo-Controlled Outcome Trials

Back

HFA Premium Access

Timing of Cardio-Kidney Protection with SGLT2 Inhibitors: Insights from Four Large-scale Placebo-Controlled Outcome Trials

Session: Late breaking clinical trials I

Topic: Pharmacotherapy

Speaker: Doctor M. Vaduganathan (Boston, US)

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Doctor Muthiah Vaduganathan

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

31 presentations

6 followers

9 more presentations in this session

Discussant review - CANVAS Program, CREDENCE, DAPA-HF, and DELIVER

Speaker: Professor M. Packer (Dallas, US)

Access

Slides

Video

Intravenous iron therapy with ferric carboxymaltose results in a rapid and sustained rise in myocardial iron content through a non-canonical pathway: a translational study

Speaker: Associate Professor S. Lakhal-Littleton (Oxford, GB)

Access

Slides

Video

Discussant review - IV iron and the heart

Speaker: Professor E. Jankowska (Wroclaw, PL)

Access

Slides

Video

Impact of a remote monitoring program on all-cause mortality of patients with heart failure: National, real-world evidence of the TELESAT study

Speaker: Professor N. Girerd (Nancy, FR)

Access

Slides

Video

Discussant review - TELESAT

Speaker: Doctor M. Costanzo (Naperville, US)

Access

Slides

Video

Access the full session

Late breaking clinical trials I

Speakers: Doctor M. Vaduganathan, Professor M. Packer, Associate Professor S. Lakhal-Littleton, Professor E. Jankowska, Professor N. Girerd...

Access

Video

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources